71 related articles for article (PubMed ID: 26437164)
1. Leukemia cutis with lymphoglandular bodies: a clue to acute lymphoblastic leukemia cutis.
Obiozor C; Ganguly S; Fraga GR
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437164
[TBL] [Abstract][Full Text] [Related]
2. Leukemia Cutis in Relapsed Acute Myeloid Leukemia: A Call for Distinct Classification.
Nahm WJ; Juarez M; Abdul-Hay M; Bhatt A; Meehan SA; Shvartsbeyn M
Am J Case Rep; 2024 May; 25():e943577. PubMed ID: 38760926
[TBL] [Abstract][Full Text] [Related]
3. Unlocking the therapeutic potential of targeting
Samiksha S; Chan LN
Haematologica; 2024 May; 109(5):1317-1319. PubMed ID: 37916388
[No Abstract] [Full Text] [Related]
4. Precursor B-cell lymphoblastic lymphoma presenting as concurrent enlarging masses on the scalp and postauricular region in a 13-year-old boy.
Wang WY; Yang SF; Cheng YW; Chen YY
Kaohsiung J Med Sci; 2024 May; 40(5):509-510. PubMed ID: 38363159
[No Abstract] [Full Text] [Related]
5. Philadelphia chromosome-like B-acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation.
Cheng J; Svoronos N; Pan M; Smith S; Vatsayan A; Jacobsohn D; Wistinghausen B
Pediatr Blood Cancer; 2024 Jun; 71(6):e30963. PubMed ID: 38523244
[No Abstract] [Full Text] [Related]
6. Leukemia Cutis-The Current View on Pathogenesis, Diagnosis, and Treatment.
Robak E; Braun M; Robak T
Cancers (Basel); 2023 Nov; 15(22):. PubMed ID: 38001655
[TBL] [Abstract][Full Text] [Related]
7. A single scalp nodule as the first presentation of acute lymphoblastic leukemia (
Pellegrino F; Coppo P; Barisone E; Bertorello N; Spadea M; Fagioli F
Front Pediatr; 2023; 11():1254274. PubMed ID: 38143534
[TBL] [Abstract][Full Text] [Related]
8. A case of leukemia cutis showing annular erythema during the course of Philadelphia chromosome-positive acute B-lymphoblastic leukemia.
Tomita H; Nobeyama Y; Sakayori Y; Matsumoto R; Chujo S; Suzuki H; Asahina A
Clin Case Rep; 2024 Feb; 12(2):e8474. PubMed ID: 38344344
[TBL] [Abstract][Full Text] [Related]
9. Aleukemic congenital leukemia cutis preceding monocytic leukemia with favorable outcome: A case report.
Lo Presti C; Szymanski G; Lefebvre C; Jacob MC; Mossuz P; Gil H
EJHaem; 2024 Feb; 5(1):162-165. PubMed ID: 38406553
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic evidence of chimeric antigen receptor T-cell therapy in lesions of B-cell lymphoblastic leukemia cutis.
Nihal A; Comstock JR; Bennett DD; Mattison RJ; Nadiminti KVG; Keenan T
J Cutan Pathol; 2024 Feb; ():. PubMed ID: 38366895
[No Abstract] [Full Text] [Related]
11. Plum-colored plaques on the scalp and extremities.
Hussain AN; Guo EL; Cardis MA
JAAD Case Rep; 2021 Mar; 9():21-23. PubMed ID: 33598520
[No Abstract] [Full Text] [Related]
12. Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation.
Konuma T; Kanda J; Uchida N; Nishijima A; Tanaka M; Ozawa Y; Sawa M; Onizuka M; Ota S; Maruyama Y; Kanda Y; Kawakita T; Ara T; Eto T; Nakamae H; Kimura T; Fukuda T; Atsuta Y;
Hematol Oncol; 2023 Feb; 41(1):147-158. PubMed ID: 36268564
[TBL] [Abstract][Full Text] [Related]
13. Guidelines for the treatment of chronic myeloid leukemia from the NCCN and ELN: differences and similarities.
Narlı Özdemir Z; Kılıçaslan NA; Yılmaz M; Eşkazan AE
Int J Hematol; 2023 Jan; 117(1):3-15. PubMed ID: 36064839
[TBL] [Abstract][Full Text] [Related]
14. Treatment patterns, health care resource utilization, and costs associated with use of atypical antipsychotics as first vs subsequent adjunctive treatment in major depressive disorder.
Jain R; Laliberté F; Germain G; Mahendran M; Higa S; Harrington A; Parikh M
J Manag Care Spec Pharm; 2023 Aug; 29(8):896-906. PubMed ID: 37523314
[No Abstract] [Full Text] [Related]
15. Alcohol drinking in male patients with chronic schizophrenia: prevalence and its relationship to clinical symptoms.
Lv M; Wang X; Wang Z; Li X; Wang L; Tan Y; Zhang XY
Front Psychiatry; 2023; 14():1164968. PubMed ID: 37520222
[TBL] [Abstract][Full Text] [Related]
16. Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph
Hirabayashi S; Kondo T; Nishiwaki S; Mizuta S; Doki N; Fukuda T; Uchida N; Ozawa Y; Kanda Y; Imanaka R; Takahashi S; Ishikawa J; Yano S; Nakamae H; Eto T; Kimura T; Tanaka J; Ichinohe T; Atsuta Y; Kako S
Am J Hematol; 2023 Oct; 98(10):1606-1618. PubMed ID: 37493218
[TBL] [Abstract][Full Text] [Related]
17. Saliva as a noninvasive sampling matrix for therapeutic drug monitoring of intravenous busulfan in Chinese patients undergoing hematopoietic stem cell transplantation: A prospective population pharmacokinetic and simulation study.
Xu B; Yang T; Zhou J; Zheng Y; Wang J; Liu Q; Li D; Zhang Y; Liu M; Wu X
CPT Pharmacometrics Syst Pharmacol; 2023 Sep; 12(9):1238-1249. PubMed ID: 37491812
[TBL] [Abstract][Full Text] [Related]
18. Combination of venetoclax with BCR-ABL tyrosine kinase inhibitor as a therapeutic strategy for Philadelphia chromosome-positive leukemias.
Zou JY; Huang SM; Zhoub HX; Xu MZ; Sun AN; Wu DP; Xue SL; Zhang TT
Hematology; 2023 Dec; 28(1):2237790. PubMed ID: 37477259
[TBL] [Abstract][Full Text] [Related]
19. High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT Study.
Nishiwaki S; Sugiura I; Fujisawa S; Hatta Y; Atsuta Y; Doki N; Kurahashi S; Ueda Y; Dobashi N; Maeda T; Taniguchi Y; Tanaka M; Kako S; Ichinohe T; Fukuda T; Ohtake S; Ishikawa Y; Kiyoi H; Matsumura I; Miyazaki Y
Hemasphere; 2023 Jun; 7(6):e899. PubMed ID: 37475881
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
